Replies to post #626404 on NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

Maybe a bigger magnet might do the trick. Good luck.

[norisknorewards]

I bet you sell 3 Kia's a month in their pre-owned dept.!

[Smitty5150]

If you think NW is going CH11, those days are long gone. If they survived the past 5 years, they will thrive now with P3 data on-hand and on the cusp of MHRA and possible FDA submittal in the next 2 months. As far as "their vaccine barely moving the needle"...its the biggest break-through in GBM in over 30 years. NW has 70 authors who are experts in the field, and much more knowledgeable than you and I combined, in what would would be considered "statically significant" in terms on in GBM...and that long tail, let not forget that. I will trust doctors who do this stuff for a living over any message board poster. And the lets not forget the combo trial at UCLA...50% survival at 5 years. BP wants a piece of that, and wants it bad. But hey, good luck with your your glass-half-empty investing philosophy. To each his own.

[Long and gone]

This is a plainly stupid post. This is how biotechs go. People with no shares that post have an agenda that’s not ethical. Good luck

[CherryTree1]

Look at the revenue projections not the current balance sheet.
There are roughly 22,000 new cases of GBM in Europe alone each year.
At $250,000 per DCVAX-L treatment that is $5,500,000,000 in revenue. Double that for the USA.
DCVAX will be effective for pretty much any sold tumor cancer.
Look at the new cases below.
Read it and weep.